Cargando…
Complications Risk Assessment and Imaging Findings of Thermal Ablation Treatment in Liver Cancers: What the Radiologist Should Expect
One of the major fields of application of ablation treatment is liver tumors. With respect to HCC, ablation treatments are considered as upfront treatments in patients with early-stage disease, while in colorectal liver metastases (CLM), they can be employed as an upfront treatment or in association...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9147303/ https://www.ncbi.nlm.nih.gov/pubmed/35628893 http://dx.doi.org/10.3390/jcm11102766 |
_version_ | 1784716774237798400 |
---|---|
author | Granata, Vincenza Fusco, Roberta De Muzio, Federica Cutolo, Carmen Setola, Sergio Venanzio Simonetti, Igino Dell’Aversana, Federica Grassi, Francesca Bruno, Federico Belli, Andrea Patrone, Renato Pilone, Vincenzo Petrillo, Antonella Izzo, Francesco |
author_facet | Granata, Vincenza Fusco, Roberta De Muzio, Federica Cutolo, Carmen Setola, Sergio Venanzio Simonetti, Igino Dell’Aversana, Federica Grassi, Francesca Bruno, Federico Belli, Andrea Patrone, Renato Pilone, Vincenzo Petrillo, Antonella Izzo, Francesco |
author_sort | Granata, Vincenza |
collection | PubMed |
description | One of the major fields of application of ablation treatment is liver tumors. With respect to HCC, ablation treatments are considered as upfront treatments in patients with early-stage disease, while in colorectal liver metastases (CLM), they can be employed as an upfront treatment or in association with surgical resection. The main prognostic feature of ablation is the tumor size, since the goal of the treatment is the necrosis of all viable tumor tissue with an adequate tumor-free margin. Radiofrequency ablation (RFA) and microwave ablation (MWA) are the most employed ablation techniques. Ablation therapies in HCC and liver metastases have presented a challenge to radiologists, who need to assess response to determine complication-related treatment. Complications, defined as any unexpected variation from a procedural course, and adverse events, defined as any actual or potential injury related to the treatment, could occur either during the procedure or afterwards. To date, RFA and MWA have shown no statistically significant differences in mortality rates or major or minor complications. To reduce the rate of major complications, patient selection and risk assessment are essential. To determine the right cost-benefit ratio for the ablation method to be used, it is necessary to identify patients at high risk of infections, coagulation disorders and previous abdominal surgery interventions. Based on risk assessment, during the procedure as part of surveillance, the radiologists should pay attention to several complications, such as vascular, biliary, mechanical and infectious. Multiphase CT is an imaging tool chosen in emergency settings. The radiologist should report technical success, treatment efficacy, and complications. The complications should be assessed according to well-defined classification systems, and these complications should be categorized consistently according to severity and time of occurrence. |
format | Online Article Text |
id | pubmed-9147303 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-91473032022-05-29 Complications Risk Assessment and Imaging Findings of Thermal Ablation Treatment in Liver Cancers: What the Radiologist Should Expect Granata, Vincenza Fusco, Roberta De Muzio, Federica Cutolo, Carmen Setola, Sergio Venanzio Simonetti, Igino Dell’Aversana, Federica Grassi, Francesca Bruno, Federico Belli, Andrea Patrone, Renato Pilone, Vincenzo Petrillo, Antonella Izzo, Francesco J Clin Med Review One of the major fields of application of ablation treatment is liver tumors. With respect to HCC, ablation treatments are considered as upfront treatments in patients with early-stage disease, while in colorectal liver metastases (CLM), they can be employed as an upfront treatment or in association with surgical resection. The main prognostic feature of ablation is the tumor size, since the goal of the treatment is the necrosis of all viable tumor tissue with an adequate tumor-free margin. Radiofrequency ablation (RFA) and microwave ablation (MWA) are the most employed ablation techniques. Ablation therapies in HCC and liver metastases have presented a challenge to radiologists, who need to assess response to determine complication-related treatment. Complications, defined as any unexpected variation from a procedural course, and adverse events, defined as any actual or potential injury related to the treatment, could occur either during the procedure or afterwards. To date, RFA and MWA have shown no statistically significant differences in mortality rates or major or minor complications. To reduce the rate of major complications, patient selection and risk assessment are essential. To determine the right cost-benefit ratio for the ablation method to be used, it is necessary to identify patients at high risk of infections, coagulation disorders and previous abdominal surgery interventions. Based on risk assessment, during the procedure as part of surveillance, the radiologists should pay attention to several complications, such as vascular, biliary, mechanical and infectious. Multiphase CT is an imaging tool chosen in emergency settings. The radiologist should report technical success, treatment efficacy, and complications. The complications should be assessed according to well-defined classification systems, and these complications should be categorized consistently according to severity and time of occurrence. MDPI 2022-05-13 /pmc/articles/PMC9147303/ /pubmed/35628893 http://dx.doi.org/10.3390/jcm11102766 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Granata, Vincenza Fusco, Roberta De Muzio, Federica Cutolo, Carmen Setola, Sergio Venanzio Simonetti, Igino Dell’Aversana, Federica Grassi, Francesca Bruno, Federico Belli, Andrea Patrone, Renato Pilone, Vincenzo Petrillo, Antonella Izzo, Francesco Complications Risk Assessment and Imaging Findings of Thermal Ablation Treatment in Liver Cancers: What the Radiologist Should Expect |
title | Complications Risk Assessment and Imaging Findings of Thermal Ablation Treatment in Liver Cancers: What the Radiologist Should Expect |
title_full | Complications Risk Assessment and Imaging Findings of Thermal Ablation Treatment in Liver Cancers: What the Radiologist Should Expect |
title_fullStr | Complications Risk Assessment and Imaging Findings of Thermal Ablation Treatment in Liver Cancers: What the Radiologist Should Expect |
title_full_unstemmed | Complications Risk Assessment and Imaging Findings of Thermal Ablation Treatment in Liver Cancers: What the Radiologist Should Expect |
title_short | Complications Risk Assessment and Imaging Findings of Thermal Ablation Treatment in Liver Cancers: What the Radiologist Should Expect |
title_sort | complications risk assessment and imaging findings of thermal ablation treatment in liver cancers: what the radiologist should expect |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9147303/ https://www.ncbi.nlm.nih.gov/pubmed/35628893 http://dx.doi.org/10.3390/jcm11102766 |
work_keys_str_mv | AT granatavincenza complicationsriskassessmentandimagingfindingsofthermalablationtreatmentinlivercancerswhattheradiologistshouldexpect AT fuscoroberta complicationsriskassessmentandimagingfindingsofthermalablationtreatmentinlivercancerswhattheradiologistshouldexpect AT demuziofederica complicationsriskassessmentandimagingfindingsofthermalablationtreatmentinlivercancerswhattheradiologistshouldexpect AT cutolocarmen complicationsriskassessmentandimagingfindingsofthermalablationtreatmentinlivercancerswhattheradiologistshouldexpect AT setolasergiovenanzio complicationsriskassessmentandimagingfindingsofthermalablationtreatmentinlivercancerswhattheradiologistshouldexpect AT simonettiigino complicationsriskassessmentandimagingfindingsofthermalablationtreatmentinlivercancerswhattheradiologistshouldexpect AT dellaversanafederica complicationsriskassessmentandimagingfindingsofthermalablationtreatmentinlivercancerswhattheradiologistshouldexpect AT grassifrancesca complicationsriskassessmentandimagingfindingsofthermalablationtreatmentinlivercancerswhattheradiologistshouldexpect AT brunofederico complicationsriskassessmentandimagingfindingsofthermalablationtreatmentinlivercancerswhattheradiologistshouldexpect AT belliandrea complicationsriskassessmentandimagingfindingsofthermalablationtreatmentinlivercancerswhattheradiologistshouldexpect AT patronerenato complicationsriskassessmentandimagingfindingsofthermalablationtreatmentinlivercancerswhattheradiologistshouldexpect AT pilonevincenzo complicationsriskassessmentandimagingfindingsofthermalablationtreatmentinlivercancerswhattheradiologistshouldexpect AT petrilloantonella complicationsriskassessmentandimagingfindingsofthermalablationtreatmentinlivercancerswhattheradiologistshouldexpect AT izzofrancesco complicationsriskassessmentandimagingfindingsofthermalablationtreatmentinlivercancerswhattheradiologistshouldexpect |